CAS: 1201913-82-7 - Spiro[isobenzofuran-1(3H),2′-[2H]pyran]-3′,4′,5′-triol, 6-[(4-ethylphenyl)methyl]-3′,4′,5′,6′-tetrahydro-6′-(hydroxymethyl)-, hydrate (1:1), (1S,3′R,4′S,5′S,6′R)-

Formule : C₂₂H₂₆O₆·H₂O

InChI : InChI=1S/C22H26O6.H2O/c1-2-13-3-5-14(6-4-13)9-15-7-8-16-12-27-22(17(16)10-15)21(26)20(25)19(24)18(11-23)28-22;/h3-8,10,18-21,23-26H,2,9,11-12H2,1H3;1H2/t18-,19-,20+,21-,22+;/m1./s1

Code InChI : InChIKey=ZXOCGDDVNPDRIW-NHFZGCSJSA-N

SMILES : O.OCC1OC2(OCC3=CC=C(C=C32)CC4=CC=C(C=C4)CC)C(O)C(O)C1O

Synonymes :

• Tofogliflozin hydrate
• Deberza
• Spiro[isobenzofuran-1(3H),2′-[2H]pyran]-3′,4′,5′-triol, 6-[(4-ethylphenyl)methyl]-3′,4′,5′,6′-tetrahydro-6′-(hydroxymethyl)-, hydrate (1:1), (1S,3′R,4′S,5′S,6′R)-

TOFOGLIFLOZIN

CAS : 1201913-82-7

• Formule : C₂₂H₂₈O₇
• Degré de pureté : 98%
• Masse moléculaire : 404.4535

Tofogliflozin (hydrate)

CAS : 1201913-82-7

Tofogliflozin hydrate (CSG-452 hydrate) is a potent and highly specific inhibitor of SGLT2(Ki of 2.9 …

• Formule : C₂₂H₂₈O₇
• Degré de pureté : 97.02% - 98.78%
• Couleur et forme : Solid
• Masse moléculaire : 404.45

Tofogliflozin (hydrate)

CAS : 1201913-82-7

Tofogliflozin is a novel oral anti-diabetic drug that belongs to the class of glp-1r agonists. …

• Formule : C₂₂H₂₈O₇
• Degré de pureté : Min. 95%
• Masse moléculaire : 404.45 g/mol